• DOI:10.3205/000220
• Corpus ID: 4980414

Guillain-Barré syndrome: clinical profile and management

@article{Sudulagunta2015GuillainBarrSC,
  title={Guillain-Barr{\'e} syndrome: clinical profile and management},
  author={Sreenivasa Rao Sudulagunta and Mahesh Babu Sodalagunta and Mona Sepehrar and Hadi Khorram and Shiva Kumar Bangalore Raja and Shyamala Krishnaswamy Kothandapani and Zahra Noroozpour and Mohammed Aheta Sham and Nagendra K. Prasad and Sony Parethu Sunny and Munawar Dhanish Mohammed and Rekha Gangadharappa and Ranjitha Nidsale Sudarshan},
  journal={GMS German Medical Science},
  year={2015},
  volume={13}
}

• Sreenivasa Rao Sudulagunta, Mahesh Babu Sodalagunta, +10 authors Ranjitha Nidsale Sudarshan
• Published 21 September 2015
• Medicine
• GMS German Medical Science

Introduction: Guillain-Barré syndrome (GBS) is a fulminant polyradiculoneuropathy that is acute, frequently severe and autoimmune in nature. Etiology of GBS is incompletely understood, prognosis is usually good with early detection and prompt treatment. This retrospective study was done to evaluate clinical profile, epidemiological, laboratory, and electrodiagnostic features of patients with GBS and mode of management, complications and prognostic factors. Methods: Data of 1,166 patients admitted with GBS or presented to outpatient department (previous medical records) with GBS between January 2003 and January 2014 were analyzed. Results: No difference in genders noted. Around 35% of patients are above 50 years of age. Poor control of diabetes with mean HbA1c of 8.1 ± 2.11 is found on analysis. Seasonal occurrence in GBS is prominent in winter 484 (41.50%) and mechanically ventilated were 449 (38.50%) patients. 48 (4.11%) deaths were attributed to GBS. Neurological analysis revealed cranial nerve involvement in 407 (34.90%) patients, facial palsy in 401 (34.39%) and ataxia in 88 (7.54%) patients. Most patients in plasma exchange group belonged to the lower socio-economic status. Mean cerebrospinal fluid (CSF) protein levels was (n=962) 113.8 ± 11.8 mg/dl. Conduction block determined indirectly by absent H-reflex was noted in 891 (90.64%) patients. No difference in complications and outcome is found in treatment regimens of intravenous immunoglobulin (IVIG) and plasma exchange. Conclusion: Seasonal occurrence predominantly in winter is noted. Peak flow test may be a predictor of assessing requirement of mechanical ventilation and prognosis. Conduction block is the major abnormality noted in electrophysiological studies and proximal nerve segment assessing with Erb’s point stimulation has high predictive value. IVIG treatment is more expensive but is associated with less duration of hospital stay.